Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学AML, Myeloid Malignancy Cell Therapy

Saar Gill

MD

🏢University of Pennsylvania🌐USA

Associate Professor of Medicine

35
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Saar Gill at the University of Pennsylvania is developing CAR-T approaches for AML and other myeloid malignancies — a significantly more challenging application than B cell malignancies due to shared antigen expression on normal hematopoietic cells. His work on tandem CAR designs, logic-gated CARs, and conditional antigen targeting aims to achieve selectivity for leukemic cells while sparing normal hematopoiesis.

Share:

🧪Research Fields 研究领域

AML
myeloid antigen CAR-T
CD123
CD33
solid tumor CAR-T

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-02-01 | All information from publicly available academic sources

关注 Saar Gill 的研究动态

Follow Saar Gill's research updates

留下邮箱,当我们发布与 Saar Gill(University of Pennsylvania)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment